Adrenocortical Tumors and Pheochromocytoma/Paraganglioma Initially Mistaken as Neuroblastoma-Experiences From the GPOH-MET Registry.
Kuhlen M, Pamporaki C, Kunstreich M, Wudy SA, Hartmann MF, Peitzsch M, Vokuhl C, Seitz G, Kreissl MC, Simon T, Hero B, Frühwald MC, Vorwerk P, Redlich A.
Front Endocrinol (Lausanne). 2022 Jun 17;13:918435. doi: 10.3389/fendo.2022.918435. eCollection 2022.
Beckwith-Wiedemann Syndrome.
Shuman C, Kalish JM, Weksberg R.
2000 Mar 3 [updated 2023 Sep 21]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
Adrenal neoplasms.
Low G, Dhliwayo H, Lomas DJ.
Clin Radiol. 2012 Oct;67(10):988-1000. doi: 10.1016/j.crad.2012.02.005. Epub 2012 Apr 7.
Neuroblastoma associated with adrenocortical defects.
Blatt J, Lee PA, Taylor SR.
Pediatrics. 1988 Nov;82(5):790-2.
Prenatal presentation of an adrenocortical tumor.
Schwartz JH, Smith E.
Cancer Rep (Hoboken). 2022 Oct;5(10):e1670. doi: 10.1002/cnr2.1670. Epub 2022 Sep 2.
Composite Adrenocortical Carcinoma and Neuroblastoma in an Infant With a TP53 Germline Mutation: A Case Report and Literature Review.
Tang YJ, Yu TT, Ma J, Zhou Y, Xu M, Gao YJ.
J Pediatr Hematol Oncol. 2019 Jul;41(5):399-401. doi: 10.1097/MPH.0000000000001205.
Simultaneous Adrenocortical Carcinoma and Neuroblastoma in an Infant With a Novel Germline p53 Mutation.
Courtney R, Ranganathan S.
J Pediatr Hematol Oncol. 2015 Apr;37(3):215-8. doi: 10.1097/MPH.0000000000000281.
Occurrence of Neuroblastoma among TP53 p.R337H Carriers.
Seidinger AL, Fortes FP, Mastellaro MJ, Cardinalli IA, Zambaldi LG, Aguiar SS, Yunes JA.
PLoS One. 2015 Oct 9;10(10):e0140356. doi: 10.1371/journal.pone.0140356. eCollection 2015.
A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma.
Weiner AK, Radaoui AB, Tsang M, Martinez D, Sidoli S, Conkrite KL, Delaidelli A, Modi A, Rokita JL, Patel K, Lane MV, Zhang B, Zhong C, Ennis B, Miller DP, Brown MA, Rathi KS, Raman P, Pogoriler J, Bhatti T, Pawel B, Glisovic-Aplenc T, Teicher B, Erickson SW, Earley EJ, Bosse KR, Sorensen PH, Krytska K, Mosse YP, Havenith KE, Zammarchi F, van Berkel PH, Smith MA, Garcia BA, Maris JM, Diskin SJ.
bioRxiv [Preprint]. 2024 Jan 7:2023.12.06.570390. doi: 10.1101/2023.12.06.570390.
The PI3K/Akt Pathway in Tumors of Endocrine Tissues.
Robbins HL, Hague A.
Front Endocrinol (Lausanne). 2016 Jan 11;6:188. doi: 10.3389/fendo.2015.00188. eCollection 2015.
